Carter's (CRI) Tops Q2 EPS by 13c ; Offers FY23 Guidance
Get Alerts CRI Hot Sheet
Price: $33.55 +1.21%
EPS Growth %: +20.3%
Financial Fact:
Operating income: 130.89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +20.3%
Financial Fact:
Operating income: 130.89M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
(Updated - July 28, 2023 6:40 AM EDT)
Carter's (NYSE: CRI) reported Q2 EPS of $0.64, $0.13 better than the analyst estimate of $0.51. Revenue for the quarter came in at $600 million versus the consensus estimate of $601.21 million.
GUIDANCE:
Carter's sees FY 2023 EPS of $5.95-$6.15, versus the consensus of $5.92. Carter's sees FY 2023 revenue of $2.95-3 billion, versus the consensus of $2.995 billion.
For earnings history and earnings-related data on Carter's (CRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral
- Lynx Equity sees Micron and SanDisk breakout as volatility normalizes
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share